PBS Biotechnology specializes in the development of chemiluminescent and alkaline phosphatase reagents for in vitro diagnostics, utilizing automated screening and innovative coupling techniques. The company provides high-quality raw materials and custom reagent solutions to address the need for reliable diagnostic tools in various medical applications.
Funding
Funding not disclosed
Founders
Product
Problem
In vitro diagnostic (IVD) reagent development requires reliable raw materials and efficient reagent solutions, but current options may lack the necessary quality or customization for specific medical applications. Existing reagent development processes can be slow and may not fully leverage automation and innovative techniques.
Solution
PBS Biotechnology specializes in providing high-quality chemiluminescent and alkaline phosphatase reagents, along with custom reagent solutions, to address the challenges in IVD reagent development. The company utilizes automated screening and innovative coupling techniques to enhance the efficiency and reliability of reagent production. PBS Biotechnology offers a comprehensive solution for IVD reagent development, delivering raw materials, coupled intermediates, and bulk reagent products tailored to customer needs. Their services cater to both established and emerging IVD companies seeking to improve their diagnostic tools.
Target Audience
PBS Biotechnology serves IVD companies, including both established market leaders and emerging businesses, that require high-quality reagents and customized solutions for their diagnostic assays.
Features
- Automated screening of raw materials to ensure consistent quality and performance.
- Innovative coupling techniques for enhanced reagent stability and activity.
- Chemiluminescent and alkaline phosphatase reagent development expertise.
- Custom reagent solutions tailored to specific diagnostic applications.
- GMP-compliant manufacturing facilities for reliable production.
- Development methods cover chemiluminescence, including alkaline phosphatase, acridine ester, and electrochemiluminescence technology platforms.